Alteration of hormone levels in normal males given the anabolic steroid stanozolol.
Anabolic steroids have widespread metabolic effects but, to date, their proven clinical indications have been limited. Recently the 17 alpha-alkylated steroid, stanozolol, has been shown to be of value in a variety of commonly occurring vascular diseases. Its endocrine effects have received little attention and we have investigated the effect of administering a 14 d course of stanozolol (10 mg orally per day) on a variety of important hormonal pathways in nine healthy male subjects. Significant changes occurred as follows: a 55% reduction in serum testosterone levels was noted and was accompanied by reductions in 'derived' free testosterone, sex hormone binding globulin and LH levels; total T4 and T3 levels fell in association with a decrease in thyroxine binding globulin, but no alteration was detected in TSH or free T4 levels. Changes in vitamin D status, with falls in 25-hydroxycholecalciferol and vitamin D binding globulin were also observed. These effects were reversible on stopping treatment. Stanozolol therapy therefore leads to a number of hormonal changes, probably by an action at both pituitary and hepatic levels.
D000328:Adult; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D010902:Pituitary Gland / Q000187:drug effects; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism*; D013197:Stanozolol / Q000494:pharmacology*; D013737:Testis / Q000187:drug effects; D013739:Testosterone / Q000097:blood*; D013961:Thyroid Gland / Q000187:drug effects; D013963:Thyroid Hormones / Q000097:blood*; D013975:Thyroxine-Binding Proteins / Q000378:metabolism; D014807:Vitamin D / Q000378:metabolism*
D012738:Sex Hormone-Binding Globulin; D013963:Thyroid Hormones; D013975:Thyroxine-Binding Proteins; D014807:Vitamin D; D013739:Testosterone; D013197:Stanozolol; D007986:Luteinizing Hormone